Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Kidney Transplantation

  Free Subscription


Articles published in Transpl Int

Retrieve available abstracts of 144 articles:
HTML format
Text format



Single Articles


    April 2018
  1. OKADA D, Okumi M, Kakuta Y, Unagami K, et al
    Outcome of the Risk-stratified Desensitization Protocol in Donor-specific Antibody-positive Living Kidney Transplant Recipients: A Retrospective Study.
    Transpl Int. 2018 Apr 20. doi: 10.1111/tri.13269.
    PubMed     Text format     Abstract available


  2. ARSHAD A, Hodson J, Chappelow I, Inston NG, et al
    The impact of donor body mass index on outcomes after deceased kidney transplantation.
    Transpl Int. 2018 Apr 17. doi: 10.1111/tri.13263.
    PubMed     Text format     Abstract available


  3. CHATELET V, Bayat-Makoei S, Vigneau C, Launoy G, et al
    Renal transplantation outcome and social deprivation in the French Health Care system: a cohort study using the European Deprivation Index.
    Transpl Int. 2018 Apr 2. doi: 10.1111/tri.13161.
    PubMed     Text format     Abstract available


  4. CLEPER R
    Post-transplantation lymphoproliferative disease in pediatric kidney transplant recipients-early success does not mean the battle is over!
    Transpl Int. 2018;31:361-363.
    PubMed     Text format    


    March 2018
  5. MONTERO N, Redondo-Pachon D, Perez-Saez MJ, Crespo M, et al
    Dual kidney transplantation as a strategy to use expanded criteria donors: A systematic review.
    Transpl Int. 2018 Mar 27. doi: 10.1111/tri.13157.
    PubMed     Text format     Abstract available


  6. REGELE F, Kainz A, Kammer M, Beer A, et al
    Regression of left atrial diameter after kidney transplantation is associated with prolonged survival: an observational study.
    Transpl Int. 2018 Mar 25. doi: 10.1111/tri.13152.
    PubMed     Text format     Abstract available


  7. SCHMITT FCF, Salgado E, Friebe J, Schmoch T, et al
    Cell cycle arrest and cell death correlate with the extent of ischemia and reperfusion injury in patients following kidney transplantation - Results of an observational pilot study.
    Transpl Int. 2018 Mar 5. doi: 10.1111/tri.13148.
    PubMed     Text format     Abstract available


    February 2018
  8. ZAKY Z, Augustine JJ
    Hepatitis C Treatment in Kidney Transplant Recipients: The Need for Sustained Vigilance after Sustained Viral Response.
    Transpl Int. 2018 Feb 26. doi: 10.1111/tri.13143.
    PubMed     Text format     Abstract available


  9. HELDAL K, Midtvedt K, Hartmann A, Reisaeter AV, et al
    Estimated GFR in stable older kidney transplant recipients - are present algorithms valid? A national cross-sectional cohort study.
    Transpl Int. 2018 Feb 17. doi: 10.1111/tri.13137.
    PubMed     Text format     Abstract available


  10. JORGENSEN MB, Hornum M, van Hall G, Bistrup C, et al
    Reply to: Correspondence regarding the impact of kidney transplantation on insulin sensitivity.
    Transpl Int. 2018 Feb 12. doi: 10.1111/tri.13134.
    PubMed     Text format     Abstract available


  11. MOLNAR MZ, Eason JD, Gaipov A, Talwar M, et al
    History of Psychosis and Mania, and Outcomes After Kidney Transplantation.
    Transpl Int. 2018 Feb 6. doi: 10.1111/tri.13127.
    PubMed     Text format     Abstract available


    January 2018
  12. PIPPIAS M, Stel VS, Kramer A, Abad Diez JM, et al
    Access to kidney transplantation in European adults aged 75 to 84 years and related outcomes: An analysis of the ERA-EDTA Registry database.
    Transpl Int. 2018 Jan 30. doi: 10.1111/tri.13125.
    PubMed     Text format     Abstract available


  13. BERGFELD L, Werzowa J, Saemann M, Hecking M, et al
    The impact of kidney transplantation on insulin sensitivity.
    Transpl Int. 2018 Jan 29. doi: 10.1111/tri.13124.
    PubMed     Text format     Abstract available


  14. FERNANDEZ-RUIZ M, Polanco N, Garcia-Santiago A, Munoz R, et al
    Impact of anti-HCV direct antiviral agents on graft function and immunosuppressive drug levels in kidney transplant recipients: a call to attention in the mid-term follow-up.
    Transpl Int. 2018 Jan 22. doi: 10.1111/tri.13118.
    PubMed     Text format     Abstract available


  15. HELANTERA I, Raiha J, Finne P, Lempinen M, et al
    Early failure of kidney transplants in the current era - a national cohort study.
    Transpl Int. 2018 Jan 16. doi: 10.1111/tri.13115.
    PubMed     Text format     Abstract available


  16. REUSZ GS, Molnar MZ
    Are kidney transplantation outcomes improved in children weighting 15 kilograms or less in the last decades?
    Transpl Int. 2018 Jan 16. doi: 10.1111/tri.13113.
    PubMed     Text format     Abstract available


  17. MULLER YD, Nseir G, Rotman S, Vionnet J, et al
    Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
    Transpl Int. 2018 Jan 12. doi: 10.1111/tri.13111.
    PubMed     Text format     Abstract available


  18. LEE D, Whitlam JB, Cook N, Manzoor M, et al
    Lifetime end-stage kidney disease risk estimation in living kidney donor candidates remains a challenge.
    Transpl Int. 2018;31:118-120.
    PubMed     Text format    


    December 2017
  19. BANAS B, Steubl D, Renders L, Chittka D, et al
    Clinical validation of a novel ELISpot-based in vitro diagnostic assay to monitor CMV-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study.
    Transpl Int. 2017 Dec 28. doi: 10.1111/tri.13110.
    PubMed     Text format     Abstract available


  20. CHIODINI B, Herman J, Lolin K, Adams B, et al
    Outcomes of Kidney Transplantations in Children Weighing 15 Kilograms or less: a retrospective cohort study.
    Transpl Int. 2017 Dec 27. doi: 10.1111/tri.13108.
    PubMed     Text format     Abstract available


  21. AYAZ-SHAH AA, Hussain S, Knight SR
    Do Clinical Trials Reflect Reality? A Systematic Review of Inclusion/Exclusion Criteria in Trials of Renal Transplant Immunosuppression.
    Transpl Int. 2017 Dec 23. doi: 10.1111/tri.13109.
    PubMed     Text format     Abstract available


  22. PELLETIER RP, Balazs I, Adams P, Rajab A, et al
    Clinical utility of C3d binding donor specific anti-HLA antibody detection by single antigen beads after kidney transplantation - a retrospective study.
    Transpl Int. 2017 Dec 19. doi: 10.1111/tri.13106.
    PubMed     Text format     Abstract available


  23. PIPPIAS M, Jager KJ, Caskey F, Casula A, et al
    Kidney transplant outcomes from older deceased donors: A paired kidney analysis by the ERA-EDTA Registry.
    Transpl Int. 2017 Dec 5. doi: 10.1111/tri.13103.
    PubMed     Text format     Abstract available


  24. GIRERD S, Girerd N, Duarte K, Legendre C, et al
    Preemptive second kidney transplantation is associated with better graft survival compared to non-preemptive second transplantation: a multicenter French 2000-2014 cohort study.
    Transpl Int. 2017 Dec 5. doi: 10.1111/tri.13105.
    PubMed     Text format     Abstract available


  25. FEHR T, Immer F
    Marginal organ allocation: old and new REALity.
    Transpl Int. 2017;30:1212-1214.
    PubMed     Text format    


    October 2017
  26. DORR CR, Oetting WS, Jacobson PA, Israni AK, et al
    Genetics of Acute Rejection after Kidney Transplantation.
    Transpl Int. 2017 Oct 14. doi: 10.1111/tri.13084.
    PubMed     Text format     Abstract available


  27. MOLNAR MZ
    Is kidney transplantation safe after careful selection of the recipients with a history of psychotic disorder?
    Transpl Int. 2017 Oct 11. doi: 10.1111/tri.13082.
    PubMed     Text format     Abstract available


  28. DHARNIDHARKA VR, Naik AS, Axelrod DA, Schnitzler MA, et al
    Center practice drives variation in choice of U.S. kidney transplant induction therapy: A retrospective analysis of contemporary practice.
    Transpl Int. 2017 Oct 7. doi: 10.1111/tri.13079.
    PubMed     Text format     Abstract available


    September 2017
  29. KOFMAN T, Pourcine F, Canoui-Poitrine F, Kamar N, et al
    Safety of renal transplantation in patients with bipolar or psychotic disorders: a retrospective study.
    Transpl Int. 2017 Sep 25. doi: 10.1111/tri.13078.
    PubMed     Text format     Abstract available


  30. FERNANDEZ-RUIZ M, Origuen J, Lora D, Lopez-Medrano F, et al
    Herpes zoster in kidney transplant recipients: protective effect of anti-CMV prophylaxis and NK cells count. A single-center cohort study.
    Transpl Int. 2017 Sep 22. doi: 10.1111/tri.13076.
    PubMed     Text format     Abstract available


  31. LIM WH, Wong G
    The "Cold" Hard Facts - Seasonal Variation in Outcomes After Kidney Transplantation.
    Transpl Int. 2017 Sep 22. doi: 10.1111/tri.13077.
    PubMed     Text format     Abstract available


  32. LEEAPHORN N, Garg N, Khankin EV, Cardarelli F, et al
    Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.
    Transpl Int. 2017 Sep 19. doi: 10.1111/tri.13075.
    PubMed     Text format     Abstract available


  33. STAPLETON CP, Conlon PJ, Phelan PJ
    Using omics to explore complications of kidney transplantation.
    Transpl Int. 2017 Sep 11. doi: 10.1111/tri.13067.
    PubMed     Text format     Abstract available


  34. ASTOR BC, Melamed ML, Mandelbrot DA, Djamali A, et al
    Seasonality of Mortality and Graft Failure among Kidney Transplant Recipients in the US.
    Transpl Int. 2017 Sep 4. doi: 10.1111/tri.13047.
    PubMed     Text format     Abstract available


  35. FILLER G, Ferris M
    We have to do more for former paediatric renal transplant recipients!
    Transpl Int. 2017 Sep 2. doi: 10.1111/tri.13058.
    PubMed     Text format     Abstract available


  36. GRIMBERT P
    Toward a better risk stratification for late antibody-mediated rejection in ABO incompatible kidney recipients.
    Transpl Int. 2017;30:863-864.
    PubMed     Text format    


    August 2017
  37. ENDEN K, Tainio J, Jalanko H, Jahnukainen K, et al
    Lower quality of life in young men after pediatric kidney transplantation when compared to healthy controls and survivors of childhood leukemia - a cross-sectional study.
    Transpl Int. 2017 Aug 29. doi: 10.1111/tri.13040.
    PubMed     Text format     Abstract available


  38. LAUTERIO A, De Carlis R, Di Sandro S, Ferla F, et al
    Bovine pericardium for multiple artery reconstruction in kidney transplantation.
    Transpl Int. 2017 Aug 23. doi: 10.1111/tri.13039.
    PubMed     Text format     Abstract available


  39. KHALID U, Ilham MA, Awad M, Elker D, et al
    Correspondence to: 'Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national French survey study'.
    Transpl Int. 2017 Aug 10. doi: 10.1111/tri.13019.
    PubMed     Text format     Abstract available


  40. LUQUE S, Lucia M, Bestard O
    Refinement of Humoral Immune-monitoring in Kidney Transplantation: the role of "hidden" Alloreactive Memory B cells.
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13014.
    PubMed     Text format     Abstract available


  41. ASSALINO M, Hadaya K, Andres A, Berney T, et al
    Discordant rejection in simultaneous pancreas and kidney transplantation: true discordance or analysis artefact ?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13017.
    PubMed     Text format     Abstract available


  42. GAYNOR JJ, Ciancio G
    Clinical depression as an unfavorable prognostic factor following kidney transplantation - How can we explain it?
    Transpl Int. 2017 Aug 4. doi: 10.1111/tri.13012.
    PubMed     Text format     Abstract available


  43. LENTINE KL, Naik AS, Ouseph R, Zhang Z, et al
    Antidepressant medication use before and after kidney transplant: implications for outcomes - A retrospective study.
    Transpl Int. 2017 Aug 3. doi: 10.1111/tri.13006.
    PubMed     Text format     Abstract available


    July 2017
  44. DELTOMBE C, Gillaizeau F, Anglicheau D, Morelon E, et al
    Is Pre-transplant sensitization against Angiotensin II Type1 Receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti HLA Luminex era?
    Transpl Int. 2017 Jul 7. doi: 10.1111/tri.13009.
    PubMed     Text format     Abstract available


  45. TORRES IB, Reisaeter AV, Moreso F, Asberg A, et al
    Tacrolimus and mycophenolate regimen and subclinical tubulo-interstitial inflammation in low immunological risk renal transplants.
    Transpl Int. 2017 Jul 1. doi: 10.1111/tri.13002.
    PubMed     Text format     Abstract available


    June 2017
  46. BOBAN MD, Tiefenthaler M
    Tangential Extraperitoneal Retrorenal (TER) approach: a specified uniform technique for renal transplant biopsy.
    Transpl Int. 2017 Jun 7. doi: 10.1111/tri.12994.
    PubMed     Text format     Abstract available


  47. MORATH C, Zeier M, Susal C
    Increased risk of infection-associated death with incompatible kidney transplantations.
    Transpl Int. 2017 Jun 6. doi: 10.1111/tri.12995.
    PubMed     Text format     Abstract available


  48. WAHBA R, Suwelack B, Arns W, Cakiroglu F, et al
    Rescue Allocation and Recipient Oriented Extended Allocation in kidney transplantation - Influence of the EUROTRANSPLANT allocation system on recipient selection and graft survival for initially non-accepted organs.
    Transpl Int. 2017 Jun 2. doi: 10.1111/tri.12993.
    PubMed     Text format     Abstract available


    May 2017
  49. CREMASCHI L, von Versen R, Benzing T, Wiesener M, et al
    Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: A health economic analysis from a German perspective.
    Transpl Int. 2017 May 27. doi: 10.1111/tri.12991.
    PubMed     Text format     Abstract available


  50. NORMAND G, Brunner F, Badet L, Buron F, et al
    Pregnancy outcomes in simultaneous pancreas and kidney transplant recipients: a national french survey study.
    Transpl Int. 2017 May 13. doi: 10.1111/tri.12983.
    PubMed     Text format     Abstract available


  51. KO EJ, Yu JH, Yang CW, Chung BH, et al
    Clinical outcomes of ABO- and HLA-incompatible kidney transplantation: A nationwide cohort study.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12979.
    PubMed     Text format     Abstract available


  52. WILLICOMBE M, Goodall D, McLean AG, Taube D, et al
    Alemtuzumab dose adjusted for body weight is associated with earlier lymphocyte repletion and less infective episodes in the first year post renal transplantation.
    Transpl Int. 2017 May 11. doi: 10.1111/tri.12978.
    PubMed     Text format     Abstract available


  53. UPALA S, Sanguankeo A, Panichsillapakit T, Wijarnpreecha K, et al
    Reply to: an evolving understanding of modifiable risk factors for post-transplant mortality.
    Transpl Int. 2017;30:535.
    PubMed     Text format    


  54. RINALDI S, Horne J, Madill J
    An evolving understanding of modifiable risk factors for post-transplant mortality.
    Transpl Int. 2017;30:533-534.
    PubMed     Text format    


    April 2017
  55. GRIMBERT P, Thaunat O
    mTOR inhibitors and risk for chronic antibody-mediated rejection after kidney transplantation: Where are we now?
    Transpl Int. 2017 Apr 26. doi: 10.1111/tri.12975.
    PubMed     Text format     Abstract available


  56. PIHLSTROM HK, Gatti F, Hammarstrom C, Eide IA, et al
    Early introduction of oral paricalcitol in renal transplant recipients. An open-label randomized study.
    Transpl Int. 2017 Apr 24. doi: 10.1111/tri.12973.
    PubMed     Text format     Abstract available


  57. MCCAUGHAN JA, Courtney AE
    Successful kidney transplantation in highly sensitised, ultra-long term dialysis patients.
    Transpl Int. 2017 Apr 18. doi: 10.1111/tri.12970.
    PubMed     Text format     Abstract available


  58. LONZE BE, Bae S, Kraus ES, Holechek MJ, et al
    Outcomes and Risk Stratification for Late Antibody Mediated Rejection in Recipients of ABO-incompatible Kidney Transplants.
    Transpl Int. 2017 Apr 12. doi: 10.1111/tri.12969.
    PubMed     Text format     Abstract available


  59. VANHOVE T, Kinashi H, Nguyen TQ, Metalidis C, et al
    Tubulointerstitial expression and urinary excretion of connective tissue growth factor 3 months after renal transplantation predict interstitial fibrosis and tubular atrophy at 5 years in a retrospective cohort analysis.
    Transpl Int. 2017 Apr 8. doi: 10.1111/tri.12960.
    PubMed     Text format     Abstract available


  60. FERRARI-LACRAZ S
    Donor-specific antibodies' C1q binding: improvement in kidney graft management?
    Transpl Int. 2017;30:344-346.
    PubMed     Text format    


  61. GO H, Shin S, Kim YH, Han DJ, et al
    Refinement of the criteria for ultrastructural peritubular capillary basement membrane multilayering in the diagnosis of chronic active/acute antibody-mediated rejection.
    Transpl Int. 2017;30:398-409.
    PubMed     Text format     Abstract available


  62. AMIN I, Butler AJ, Defries G, Russell NK, et al
    A single-centre experience of Roux-en-Y enteric drainage for pancreas transplantation.
    Transpl Int. 2017;30:410-419.
    PubMed     Text format     Abstract available


    March 2017
  63. FISHMAN JA, Ikle DN, Wilkinson RA
    Discrepant Serological Assays for Pneumococcus in Renal Transplant Recipients.
    Transpl Int. 2017 Mar 27. doi: 10.1111/tri.12959.
    PubMed     Text format     Abstract available


  64. BARLOW AD, Saeb-Parsy K, Watson CJ
    An analysis of the survival outcomes of simultaneous pancreas and kidney transplantation compared to live donor kidney transplantation in patients with type 1 diabetes: a UK Transplant Registry study.
    Transpl Int. 2017 Mar 20. doi: 10.1111/tri.12957.
    PubMed     Text format     Abstract available


  65. MIHALJEVIC AL, Heger P, Dezfouli SA, Golriz M, et al
    Prophylaxis of lymphocele formation after kidney transplantation via peritoneal fenestration: a systematic review.
    Transpl Int. 2017 Mar 14. doi: 10.1111/tri.12952.
    PubMed     Text format     Abstract available


  66. DE BOER JD, Kopp WH, Ooms K, Haase-Kromwijk BJ, et al
    Abdominal organ procurement in the Netherlands - an analysis of quality and clinical impact.
    Transpl Int. 2017;30:288-294.
    PubMed     Text format     Abstract available


  67. MOKTEFI A, Parisot J, Desvaux D, Canoui-Poitrine F, et al
    C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Transpl Int. 2017;30:277-287.
    PubMed     Text format     Abstract available


    February 2017
  68. LERCH C, Kanzelmeyer NK, Ahlenstiel-Grunow T, Froede K, et al
    Belatacept after kidney transplantation in adolescents: a retrospective study.
    Transpl Int. 2017 Feb 6. doi: 10.1111/tri.12932.
    PubMed     Text format     Abstract available


    January 2017
  69. TAN SJ, Crosthwaite A, Langsford D, Obeysekere V, et al
    Mineral adaptations following kidney transplantation.
    Transpl Int. 2017 Jan 25. doi: 10.1111/tri.12925.
    PubMed     Text format     Abstract available


  70. HACHEM LD, Ghanekar A, Selzner M, Famure O, et al
    Postoperative Surgical-Site Hemorrhage After Kidney Transplantation: Incidence, Risk Factors, and Outcomes.
    Transpl Int. 2017 Jan 25. doi: 10.1111/tri.12926.
    PubMed     Text format     Abstract available


  71. BERTRAND D, Dehay J, Ott J, Sberro R, et al
    Kidney transplantation in patients with systemic sclerosis: a nationwide multicenter study.
    Transpl Int. 2017 Jan 25. doi: 10.1111/tri.12923.
    PubMed     Text format     Abstract available


  72. SIMKINS J, Morris MI, Abbo LM, Camargo JF, et al
    Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates.
    Transpl Int. 2017;30:108-109.
    PubMed     Text format    


  73. PALIN NK, Savikko J, Pasternack A, Rintala JM, et al
    Activin inhibition limits early innate immune response in rat kidney allografts-a pilot study.
    Transpl Int. 2017;30:96-107.
    PubMed     Text format     Abstract available


  74. FINK S, Tsai MH, Schnitzler P, Zeier M, et al
    The Epstein-Barr virus DNA load in the peripheral blood of transplant recipients does not accurately reflect the burden of infected cells.
    Transpl Int. 2017;30:57-67.
    PubMed     Text format     Abstract available


  75. CAILLARD S, Becmeur C, Gautier-Vargas G, Olagne J, et al
    Pre-existing donor-specific antibodies are detrimental to kidney allograft only when persistent after transplantation.
    Transpl Int. 2017;30:29-40.
    PubMed     Text format     Abstract available


    December 2016
  76. JORGENSEN MB, Hornum M, van Hall G, Bistrup C, et al
    The impact of kidney transplantation on insulin sensitivity.
    Transpl Int. 2016 Dec 21. doi: 10.1111/tri.12907.
    PubMed     Text format     Abstract available


    November 2016
  77. VAN LAECKE S, Nagler EV, Peeters P, Verbeke F, et al
    Former smoking and early and long-term graft outcome in renal transplant recipients: a retrospective cohort study.
    Transpl Int. 2016 Nov 28. doi: 10.1111/tri.12897.
    PubMed     Text format     Abstract available


  78. MALIAKKAL JG, Brennan DC, Goss C, Horwedel TA, et al
    Ureteral Stent Placement and Immediate Graft Function are associated with Increased Risk of BK Viremia in the First Year after Kidney Transplantation.
    Transpl Int. 2016 Nov 18. doi: 10.1111/tri.12888.
    PubMed     Text format     Abstract available


  79. KAUKE T, Oberhauser C, Lin V, Coenen M, et al
    De novo donorspecific anti-HLA antibodies after kidney transplantation are associated with impaired graft outcome independently of their C1q-binding ability.
    Transpl Int. 2016 Nov 18. doi: 10.1111/tri.12887.
    PubMed     Text format     Abstract available


    October 2016
  80. DE MEESTER J
    The expanded criteria donor for kidney transplant: not a nearly new car.
    Transpl Int. 2016 Oct 25. doi: 10.1111/tri.12880.
    PubMed     Text format     Abstract available


  81. RUMMO OO, Carmellini M, Rostaing L, Oberbauer R, et al
    ADHERE: Randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus MMF or sirolimus.
    Transpl Int. 2016 Oct 18. doi: 10.1111/tri.12878.
    PubMed     Text format     Abstract available


  82. WEITZ M, Sazpinar O, Schmidt M, Neuhaus TJ, et al
    Balancing competing needs in kidney transplantation: Does an allocation system prioritising children affect the renal transplant function?
    Transpl Int. 2016 Oct 12. doi: 10.1111/tri.12874.
    PubMed     Text format     Abstract available


  83. MALHEIRO J, Tafulo S, Dias L, Martins S, et al
    Determining donor-specific antibodies C1q-binding ability improves the prediction of antibody-mediated rejection in HLA-incompatible kidney transplantation.
    Transpl Int. 2016 Oct 7. doi: 10.1111/tri.12873.
    PubMed     Text format     Abstract available


  84. ROSTAING L, Alric L, Kamar N
    Use of direct-acting agents for HCV-positive kidney-transplant candidates and kidney-transplant recipients.
    Transpl Int. 2016 Oct 7. doi: 10.1111/tri.12870.
    PubMed     Text format     Abstract available


  85. BREKKE FB, Waldum-Grevbo B, von der Lippe N, Os I, et al
    The effect of renal transplantation on quality of sleep in former dialysis patients.
    Transpl Int. 2016 Oct 1. doi: 10.1111/tri.12866.
    PubMed     Text format     Abstract available


    September 2016
  86. VAN ITTERSUM FJ, Hemke AC, Dekker FW, Hilbrands LB, et al
    Increased risk of graft failure and mortality in Dutch recipients receiving an Expanded Criteria Donor kidney transplant.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12863.
    PubMed     Text format     Abstract available


  87. CRUZADO JM, Pascual J, Sanchez-Fructuoso A, Seron D, et al
    Controlled randomized study comparing the cardiovascular profile of everolimus with tacrolimus in renal transplantation.
    Transpl Int. 2016 Sep 20. doi: 10.1111/tri.12862.
    PubMed     Text format     Abstract available


  88. SCHACHTNER T, Stein M, Reinke P
    Kidney Transplant Recipients after Nonrenal Solid Organ Transplantation Show Low Alloreactivity but an Increased Risk of Infection.
    Transpl Int. 2016 Sep 17. doi: 10.1111/tri.12856.
    PubMed     Text format     Abstract available


  89. LANFRANCO L, Olle Delahaye P, Dorr G, Del Bello A, et al
    Late isolated ocular toxoplasmosis in a belatacept-treated kidney-transplant patient.
    Transpl Int. 2016 Sep 10. doi: 10.1111/tri.12853.
    PubMed     Text format     Abstract available


    August 2016
  90. DHARNIDHARKA VR, Schnitzler MA, Chen J, Brennan DC, et al
    Differential Risks for Adverse Outcomes 3-Years after Kidney Transplantation Based on Initial Immunosuppression Regimen: A National Study.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12850.
    PubMed     Text format     Abstract available


  91. CERVERA C, Cofan F, Hernandez C, Soy D, et al
    Effect of mTOR inhibitors on CMV infection in kidney transplant recipients receiving polyclonal antilymphocyte globulins: a propensity score-matching analysis.
    Transpl Int. 2016 Aug 26. doi: 10.1111/tri.12848.
    PubMed     Text format     Abstract available


  92. LUQUE Y, Anglicheau D, Rabant M, El Karoui K, et al
    Renal safety of high-dose, sucrose-free intravenous immunoglobulin in kidney transplant recipients: an observational study.
    Transpl Int. 2016 Aug 16. doi: 10.1111/tri.12833.
    PubMed     Text format     Abstract available


  93. EISENGA MF, Minovic I, Berger SP, Kootstra-Ros JE, et al
    Iron Deficiency, Anemia and Mortality in Renal Transplant Recipients.
    Transpl Int. 2016 Aug 12. doi: 10.1111/tri.12821.
    PubMed     Text format     Abstract available


  94. BROCHOT E, Desoutter J, Presne C, De Araujo I, et al
    The association between KIR and KIR ligand genotypes and the likelihood of BK virus replication after kidney transplantation.
    Transpl Int. 2016 Aug 12. doi: 10.1111/tri.12820.
    PubMed     Text format     Abstract available


  95. BRAKEMEIER S, Kannenkeril D, Durr M, Braun T, et al
    Experience with belatacept rescue therapy in kidney transplant recipients.
    Transpl Int. 2016 Aug 12. doi: 10.1111/tri.12822.
    PubMed     Text format     Abstract available


    July 2016
  96. PALOYO S, Sageshima J, Gaynor JJ, Chen L, et al
    Negative Impact of Prolonged Cold Storage Time before Machine Perfusion Preservation in Donation after Circulatory Death Kidney Transplantation.
    Transpl Int. 2016 Jul 16. doi: 10.1111/tri.12818.
    PubMed     Text format     Abstract available


    June 2016
  97. PEREZ-JACOISTE ASIN MA, Fernandez-Ruiz M, Lopez-Medrano F, Aquilino C, et al
    Monitoring of intracellular ATP in CD4+ T-cells to predict the occurrence of cytomegalovirus disease in kidney transplant recipients.
    Transpl Int. 2016 Jun 30. doi: 10.1111/tri.12816.
    PubMed     Text format     Abstract available


  98. CENA T, Musetti C, Quaglia M, Magnani C, et al
    De novo non cutaneous malignancies after kidney transplantation are associated with an increased risk of graft failure: results from a time-dependent analysis on 672 patients.
    Transpl Int. 2016 Jun 25. doi: 10.1111/tri.12813.
    PubMed     Text format     Abstract available


  99. PEDROLLO EF, Correa C, Nicoletto BB, Manfro RC, et al
    Effects of metabolic syndrome on kidney transplantation outcomes: A systematic review and meta-analysis.
    Transpl Int. 2016 Jun 10. doi: 10.1111/tri.12805.
    PubMed     Text format     Abstract available


    May 2016
  100. AITKEN E, Little AM, Clancy M
    Prioritising renal transplantation based on clinical need: The role of an "urgent" kidney waiting list.
    Transpl Int. 2016 May 21. doi: 10.1111/tri.12801.
    PubMed     Text format     Abstract available


  101. BEINHARDT S, Al Zoairy R, Ferenci P, Kozbial K, et al
    DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and post kidney transplantation setting.
    Transpl Int. 2016 May 20. doi: 10.1111/tri.12799.
    PubMed     Text format     Abstract available


  102. PATEL SJ, Suki WN, Loucks-DeVos J, Graviss EA, et al
    Disparate rates of acute rejection and donor specific antibodies among high-immunologic risk renal transplant subgroups receiving antithymocyte globulin induction.
    Transpl Int. 2016 May 19. doi: 10.1111/tri.12791.
    PubMed     Text format     Abstract available


  103. SHUKER N, Shuker L, van Rosmalen J, Roodnat JI, et al
    A High intra-patient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantion.
    Transpl Int. 2016 May 18. doi: 10.1111/tri.12798.
    PubMed     Text format     Abstract available


  104. LACHMANN N, Schonemann C
    Tracing Clinically Relevant HLA Antibodies Prior to Kidney Transplantation.
    Transpl Int. 2016 May 14. doi: 10.1111/tri.12796.
    PubMed     Text format     Abstract available


    April 2016
  105. BACHELET T, Visentin J, Guidicelli G, Merville P, et al
    Anti-HLA donor-specific antibodies are not created equally. Don't forget the flow....
    Transpl Int. 2016;29:508-10.
    PubMed     Text format    


  106. DEMISELLE J, Augusto JF, Videcoq M, Legeard E, et al
    Transplantation of kidneys from uncontrolled donation after circulatory determination of death: comparison with brain death donors with or without extended criteria and impact of normothermic regional perfusion.
    Transpl Int. 2016;29:432-42.
    PubMed     Text format     Abstract available


  107. ALLEN R, Pleass H, Clayton PA, Woodroffe C, et al
    Outcomes of kidney paired donation transplants in relation to shipping and cold ischaemia time.
    Transpl Int. 2016;29:425-31.
    PubMed     Text format     Abstract available


  108. ESKANDARY F, Wahrmann M, Muhlbacher J, Bohmig GA, et al
    Complement inhibition as potential new therapy for antibody-mediated rejection.
    Transpl Int. 2016;29:392-402.
    PubMed     Text format     Abstract available


    March 2016
  109. WAN SS, Cantarovich M, Mucsi I, Baran D, et al
    Early Renal Function Recovery and Long-term Graft Survival in Kidney Transplantation.
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12775.
    PubMed     Text format     Abstract available


  110. NICLAUSS N, Bedat B, Morel P, Andres A, et al
    Impact of graft implantation order on graft survival in simultaneous pancreas-kidney transplantation.
    Transpl Int. 2016 Mar 14. doi: 10.1111/tri.12773.
    PubMed     Text format     Abstract available


  111. BUNNAPRADIST S, Rostaing L, Alloway RR, West-Thielke P, et al
    LCPT Once-Daily Extended-Release Tacrolimus Tablets Vs. Twice-Daily Capsules: A Pooled Analysis of Two Phase 3 Trials in Important De Novo and Stable Kidney Transplant Recipient Subgroups.
    Transpl Int. 2016 Mar 8. doi: 10.1111/tri.12770.
    PubMed     Text format     Abstract available


  112. MJOEN G, Holdaas H
    Regarding long-term outcome after kidney donation.
    Transpl Int. 2016;29:381.
    PubMed     Text format    


    February 2016
  113. KWONG J, Schiefer D, Aboalsamh G, Archambault J, et al
    Optimal management of distal ureteric strictures following renal transplantation: a systematic review.
    Transpl Int. 2016 Feb 20. doi: 10.1111/tri.12759.
    PubMed     Text format     Abstract available


  114. SVACHOVA V, Sekerkova A, Hruba P, Tycova I, et al
    Dynamic changes of B cell compartments in kidney transplantation: lack of transitional B cells is associated with allograft rejection.
    Transpl Int. 2016 Feb 3. doi: 10.1111/tri.12751.
    PubMed     Text format     Abstract available


  115. SAGASTA A, Sanchez-Escuredo A, Oppenheimer F, Paredes D, et al
    Pre-implantation analysis of kidney biopsies from expanded criteria donors: testing the accuracy of frozen section technique and the adequacy of their assessment by on-call pathologists.
    Transpl Int. 2016;29:234-40.
    PubMed     Text format     Abstract available


    January 2016
  116. QUERARD AH, Foucher Y, Combescure C, Dantan E, et al
    Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta-analysis.
    Transpl Int. 2016 Jan 12. doi: 10.1111/tri.12736.
    PubMed     Text format     Abstract available


  117. MAKSTEN EF, Vase MO, Kampmann J, d'Amore F, et al
    Post-transplant lymphoproliferative disorder following kidney transplantation: a population-based cohort study.
    Transpl Int. 2016 Jan 8. doi: 10.1111/tri.12744.
    PubMed     Text format     Abstract available


  118. THIERRY A, Lemeur Y, Ecotiere L, Abou-Ayache R, et al
    Minimization of maintenance immunosuppressive therapy after renal transplantation comparing cyclosporine A/azathioprine or cyclosporine A/mycophenolate mofetil bitherapy to cyclosporine A monotherapy: a 10-year postrandomization follow-up study.
    Transpl Int. 2016;29:23-33.
    PubMed     Text format     Abstract available


  119. BIANCONE L, Cozzi E, Lopez-Fraga M, Nanni-Costa A, et al
    Long-term outcome of living kidney donation: Position paper of the European Committee on Organ Transplantation (CD-P-TO), Council of Europe.
    Transpl Int. 2016;29:129-31.
    PubMed     Text format    


  120. PANDANABOYANA S, Longbotham D, Hostert L, Attia M, et al
    Transplantation of liver and kidney from donors with malignancy at the time of donation: an experience from a single centre.
    Transpl Int. 2016;29:73-80.
    PubMed     Text format     Abstract available


  121. FLECHNER SM
    Optimizing immunosuppression: who can do more with less?
    Transpl Int. 2016;29:20-2.
    PubMed     Text format    


    December 2015
  122. NOVOSEL MK, Bistrup C
    Discontinuation of Steroids in ABO Incompatible Renal Transplantation.
    Transpl Int. 2015 Dec 26. doi: 10.1111/tri.12735.
    PubMed     Text format     Abstract available


  123. SANCHEZ-ESCUREDO A, Diekmann F, Revuelta I, Esforzado N, et al
    An mTOR- inhibitors based protocol calcineurin inhibitor (CNI)-free in kidney transplant recipients from donors after cardiac death: Good renal function, but high incidence of conversion to CNI.
    Transpl Int. 2015 Dec 17. doi: 10.1111/tri.12732.
    PubMed     Text format     Abstract available


  124. NAGY K, Ujszaszi A, Czira ME, Remport A, et al
    Association between serum resistin level and outcomes in kidney transplant recipients.
    Transpl Int. 2015 Dec 7. doi: 10.1111/tri.12728.
    PubMed     Text format     Abstract available


    November 2015
  125. ESPOSITO L, Rostaing L, Kamar N
    Successful pregnancy after ABO-incompatible kidney transplantation.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12724.
    PubMed     Text format     Abstract available


  126. DOS SANTOS DC, Campos EF, Saraiva Camara NO, David DS, et al
    Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12726.
    PubMed     Text format     Abstract available


  127. CHAN W, Jones D, Bosch JA, McPhee J, et al
    Cardiovascular, Muscular and Perceptual Contributions to Physical Fatigue in Prevalent Kidney Transplant Recipients.
    Transpl Int. 2015 Nov 28. doi: 10.1111/tri.12727.
    PubMed     Text format     Abstract available


  128. BELLIERE J, Kamar N, Mengelle C, Allal A, et al
    Pilot conversion trial from mycophenolic acid to everolimus in ABO-incompatible kidney-transplant recipients with BK viruria and/or viremia.
    Transpl Int. 2015 Nov 17. doi: 10.1111/tri.12718.
    PubMed     Text format     Abstract available


  129. KRAMER BK, Montagnino G, Kruger B, Margreiter R, et al
    Efficacy and safety of tacrolimus compared with ciclosporin a in renal transplantation: seven-year observational results.
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12716.
    PubMed     Text format     Abstract available


  130. SCHMID A
    Percutaneous Renal Transplant Biopsy: Is the safety profile adequate for short term post procedure monitoring?
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12713.
    PubMed     Text format     Abstract available


  131. MUNDT HM, Yard BA, Kramer BK, Benck U, et al
    Optimized donor management and organ preservation before kidney transplantation.
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12712.
    PubMed     Text format     Abstract available


  132. NAIK AS, Dharnidharka VR, Schnitzler MA, Brennan DC, et al
    Clinical and Economic Consequences of First-Year Urinary Tract Infections, Sepsis and Pneumonia in Contemporary Kidney Transplantation Practice.
    Transpl Int. 2015 Nov 13. doi: 10.1111/tri.12711.
    PubMed     Text format     Abstract available


    July 2015
  133. THOMAS MN, Nadalin S, Schemmer P, Pascher A, et al
    A German survey of the abdominal transplantation surgical work force.
    Transpl Int. 2015;28:849-56.
    PubMed     Text format     Abstract available


  134. VAILAS M, Vernadakis S, Zavos G
    Tuberculous enteritis: a surgical 'Janus' masquerading as intestinal obstruction.
    Transpl Int. 2015;28:872-3.
    PubMed     Text format    


    June 2015
  135. O'NEILL S, Oniscu GC, Harrison EM
    Faster may be better for anastomosis time, but does it really affect survival?
    Transpl Int. 2015;28:764.
    PubMed     Text format    


    May 2015
  136. VAN GELDER T, Hesselink DA
    Mycophenolate revisited.
    Transpl Int. 2015;28:508-15.
    PubMed     Text format     Abstract available


  137. USLU A, Hur E, Sen C, Sen S, et al
    To what extent estimated or measured GFR could predict subclinical graft fibrosis: a comparative prospective study with protocol biopsies.
    Transpl Int. 2015;28:575-81.
    PubMed     Text format     Abstract available


  138. NOCERA A, Cioni M, Tagliamacco A, Comoli P, et al
    Serum complement inactivation unveiled prepregnancy donor-specific HLA antibodies leading to postpartum kidney graft loss.
    Transpl Int. 2015;28:623-5.
    PubMed     Text format    


  139. PIKE TW, Pandanaboyana S, Hope-Johnson T, Hostert L, et al
    Ureteric reconstruction for the management of transplant ureteric stricture: a decade of experience from a single centre.
    Transpl Int. 2015;28:529-34.
    PubMed     Text format     Abstract available


    April 2015
  140. HESSELINK DA
    When a zero mismatch is no longer superior.
    Transpl Int. 2015;28:398-400.
    PubMed     Text format    


  141. SOMMERER C, Feuerstein D, Dikow R, Rauch G, et al
    Psychosocial and physical outcome following kidney donation-a retrospective analysis.
    Transpl Int. 2015;28:416-28.
    PubMed     Text format     Abstract available


    March 2015
  142. VAN BOEKEL GA, Aarnoutse RE, Hoogtanders KE, Havenith TR, et al
    Delayed trough level measurement with the use of prolonged-release tacrolimus.
    Transpl Int. 2015;28:314-8.
    PubMed     Text format     Abstract available


    January 2015
  143. WEISMULLER TJ, Lerch C, Evangelidou E, Strassburg CP, et al
    A pocket guide to identify patients at risk for chronic kidney disease after liver transplantation.
    Transpl Int. 2015 Jan 9. doi: 10.1111/tri.12522.
    PubMed     Text format     Abstract available


    November 2014
  144. THYS K, Schwering KL, Siebelink M, Dobbels F, et al
    Psychosocial impact of pediatric living-donor kidney and liver transplantation on recipients, donors and the family: a systematic review.
    Transpl Int. 2014 Nov 1. doi: 10.1111/tri.12481.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Kidney Transplantation is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: